Point Nine Land
Published in

Point Nine Land

Vive la France! Vive Gourmey’s cell-based foie gras!

By Nathan Benaich and Christoph Janz

A little while ago we wrote about why we both invested in Mission Barns. If you haven’t read the post, d̶o̶ ̶i̶t̶ ̶n̶o̶w here’s a very brief summary:

  1. The way meat is currently produced is horrible in terms of animal welfare. It is not sustainable from an environmental point of view and is a long-term threat to the human race.
  2. But humans love meat. So we need a new way to produce meat that doesn’t require factory farming and killing of animals, that’s CO2 neutral, free of food-borne disease, antibiotics, hormones and other nasty chemicals.
  3. Mission Barns is one of the most promising startups that’s developing cultured meat.

In the meantime, Mission Barns has continued to make incredible progress towards its goal of bringing cell-based meat to the market in the near future and has raised a large Series A.

ICYMI: Today is Bastille Day. Photo by Yiwen.

Today we’re thrilled to announce our second cultivated meat investment: Gourmey.

Based in the world’s culinary capital of Paris that’s also home to the renowned Institut Pasteur and Institut Curie, Gourmey has created a cell-based alternative to a meat product that — while being loved around the world for its delicious taste — stands for one of the worst excesses of how humans are (mis)treating animals in order to turn them into food: foie gras. In case you don’t know foie gras (unlikely if you’re from France, more likely if you’re based elsewhere), foie gras is a specialty food made of the liver of a duck or a goose. To produce foie gras the “traditional” way, farmers ram pipes down the throats of geese and ducks to pump excessive amounts of grain and fat into their stomachs, which causes their livers to swell to up to ten times their normal size.

Not surprisingly, foie gras production has already been banned in seventeen countries, including Czech Republic, Denmark, Finland, Germany, Italy, Luxembourg, Norway, Poland, Turkey, and the UK. Beyond production, California has even banned the sales of the delicacy, and so has New York City (starting in 2022). If you’re an investor looking for a good “Why now?”, it doesn’t get much better than this. ;-)

Another advantage of foie gras as an entry product is that it’s very expensive. This shortens the time to cost parity for a cultivated alternative. The foie gras market today is worth $2B globally, but more interestingly, there is evidence for an untapped market in the form of consumers who would like to eat foie gras today, but do not because of the horrific treatment of animals. Ultimately, Gourmey’s product will be 10x better and cheaper, to quote another investor’s favorite. :)

On the technology front, cell-based meat is arguably one of the most exciting and impactful grand challenges of our time. There are a range of approaches out there, ranging from cellular reprogramming of mature cell types into induced pluripotent stem cells (iPSCs) to directly culturing progenitor cells of the desired cell type (e.g. immature liver cells) in adherent or suspension culture systems. Gourmey is developing an avian embryonic stem cell-based (ESC) platform that stands on the shoulders of large-scale suspension ESCs culture, an already established approach in the vaccine industry.

Dr. Marion Gaff, Food Scientist at Gourmey, assessing the texture of a foie gras prototype.

By making use of animal species-specific ESCs, Gourmey can differentiate multiple cell types to generate a range of products beyond foie gras. In fact, the company already has run taste tests for unstructured products like nuggets and texturized meats like fillets. But scalable cell culture is only part of the solution. The other major technology vector is food sciences, which encompasses the molecular engineering to achieve desired tastes and textures as well as the bioprocess engineering of all input ingredients to produce the final restaurant-grade product.

The team that’s making cruelty-free foie gras a reality!

All of this wouldn’t be possible without a resourceful multidisciplinary team full of ingenuity. Cell-based meat production is a novel frontier of biotechnology: in fact, the very first academic department for cell-based meats was only recently launched at the Technical University of Munich .

Gourmey’s founders — Nicolas, Victor, and Antoine — bring a unique combination of scientific, engineering, product, brand marketing experience, and — most importantly, authenticity and passion, that made us fall in love. They’ve built up a team of two dozen talented and dedicated Gourmates who are together making fast progress towards a commercial launch in a restaurant near you soon. :-) If you’d like to join them on that mission, check out Gourmey’s open positions here!

Vive Gourmey! ❤️ 🇫🇷 🦆

--

--

--

P9 is an early-stage VC focused on B2B SaaS and marketplaces. Point Nine Land is where the P9 team (and sometimes members of the wider P9 Family) share their thoughts on SaaS, marketplaces, startups, VC, and more.

Recommended from Medium

A Seattle Bartender’s Selections For Your Cinco De Mayo Fiesta Of Liver Obliteration

Manna From Texas — Chicken Fried Steak

Cookies Outline

Making baby food in the Instant Pot

Guide to Poultices, Tinctures, and Salves- Quick Guide for at Home Medicine

Easy Meals Anyone Can Cook

Coffee Conversation with Dr Jeffrey Neilson

Vital Earth Minerals Humic Minerals — 32 Fl.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Christoph Janz

Christoph Janz

Internet entrepreneur turned angel investor turned micro VC. Managing Partner at http://t.co/5WJ3Pepbcv.

More from Medium

Four reasons the supply chain broke in 2021…

Behind the Term Sheet: How Reebelo is Building APAC’s Circular Economy for Refurbished Electronics

Exciting promotions within our Dawn family, as Henry Mason makes Partner

Can a startup have two CEOs?